XERIS PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Chicago, IL
SEC filing record 1 source field available
Fiscal year end
31 December
XERIS PHARMACEUTICALS INC has filed 298 SEC EDGAR filings since 29 Nov 2005

SEC filing history

Showing 126-150 of 297 matching filings.

Per page
25
Current page
6
DEF 14A File 001-38536

DEF 14A

Filing date
24 Apr 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38536

8-K

Filing date
10 Apr 2020
Reporting date
10 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Mar 2020
Reporting date
13 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-237120

S-8

Filing date
12 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38536

8-K

Filing date
11 Mar 2020
Reporting date
11 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90534

SC 13G/A

Filing date
10 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90534

SC 13G filing

Filing date
21 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Feb 2020
Reporting date
14 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Feb 2020
Reporting date
14 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Feb 2020
Reporting date
14 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Feb 2020
Reporting date
14 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Feb 2020
Reporting date
14 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90534

SCHEDULE 13G HOLDINGS REPORT

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90534

SCHEDULE 13G/A

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38536

8-K

Filing date
13 Feb 2020
Reporting date
11 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-233061

424B5

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90534

SC 13G/A filing

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38536

8-K

Filing date
11 Feb 2020
Reporting date
10 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .